Cargando…

Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials

The aim of this meta-analysis of randomized placebo-controlled clinical trials was to assess the effect of ezetimibe on plasma lipoprotein(a) concentrations. Only randomized placebo-controlled trials investigating the impact of ezetimibe treatment on cholesterol lowering that include lipoprotein(a)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahebkar, Amirhossein, Simental-Mendía, Luis E., Pirro, Matteo, Banach, Maciej, Watts, Gerald F., Sirotri, Cesare, Al-Rasadi, Khalid, Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294784/ https://www.ncbi.nlm.nih.gov/pubmed/30552391 http://dx.doi.org/10.1038/s41598-018-36204-7

Ejemplares similares

Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies
por: Pirro, Matteo, et al.
Publicado: (2019)

The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jamialahmadi, Tannaz, et al.
Publicado: (2021)

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2018)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis
por: Reiner, Željko, et al.
Publicado: (2019)

Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms?
por: Sahebkar, Amirhossein, et al.
Publicado: (2016)

Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials
por: Simental-Mendía, Luis E., et al.
Publicado: (2019)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

Effects of statins on mitochondrial pathways
por: Mollazadeh, Hamid, et al.
Publicado: (2021)

Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
por: Lee, Jun-beom, et al.
Publicado: (2017)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis
por: Vahedian-Azimi, Amir, et al.
Publicado: (2021)

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

Targeting AMPK by Statins: A Potential Therapeutic Approach
por: Dehnavi, Sajad, et al.
Publicado: (2021)

Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

The role of statins in lung cancer
por: Amin, Fatemeh, et al.
Publicado: (2021)

Beneficial Effect of Statin Therapy on Arterial Stiffness
por: Alidadi, Mona, et al.
Publicado: (2021)

Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
por: Ezhov, Marat V., et al.
Publicado: (2023)

Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
por: Koushki, Khadijeh, et al.
Publicado: (2020)

Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020)

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
por: Abramson, Beth L, et al.
Publicado: (2011)

Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis
por: Bae, Jaehyun, et al.
Publicado: (2020)

The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis
por: Vahedian-Azimi, Amir, et al.
Publicado: (2022)

Cholesterol in Relation to COVID-19: Should We Care about It?
por: Radenkovic, Dina, et al.
Publicado: (2020)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
por: Penson, Peter E., et al.
Publicado: (2018)

Parenteral systems for statin delivery: a review
por: Korani, Shahla, et al.
Publicado: (2019)

Liver Injury Associated With Ezetimibe Monotherapy
por: Kanagalingam, Tharsan, et al.
Publicado: (2020)

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
por: Momtazi, Amir Abbas, et al.
Publicado: (2017)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021)

Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature
por: Yu, Min, et al.
Publicado: (2020)

Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces
por: Bianconi, Vanessa, et al.
Publicado: (2020)

Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease
por: Le, Ngoc‐Anh, et al.
Publicado: (2015)

Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia
por: Ohta, Akio, et al.
Publicado: (2017)

Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications
por: Gorabi, Armita Mahdavi, et al.
Publicado: (2019)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9b7o4hlhl4d9g7n36bg6pctjng